Answers are grounded in this paper and cite their sources.
The evolution of antimicrobial resistance has put at risk the value of broad-spectrum drugs available for the treatment of infectious diseases and has promoted the use of others such as colistin, especially in multi-resistant Enterobacterales infections, being necessary to know and define reliable methodologies that can predict its sensitivity.
No takes yet. Share an insight, caveat, or question.
Touchet et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: